Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulfonylurea: A 52‐week open‐label, randomized phase 3 trial
Wang W et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13506
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.